• Profile
Close

"Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study"

Journal of Hepatology Mar 23, 2018

Romano A, et al. - The incidence of newly diagnosed hepatocellular carcinoma and related risk factors in individuals with advanced hepatitis C treated with direct-acting antiviral agents (DAAs) was determined. The risk of de novo hepatocarcinoma during the first year was not higher, but was lower in patients with advanced hepatitis C receiving DAAs compared to untreated patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay